These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22808135)

  • 1. Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma.
    Jiang Y; Soong TD; Wang L; Melnick AM; Elemento O
    PLoS One; 2012; 7(7):e40332. PubMed ID: 22808135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of BACH2 is related to ongoing somatic hypermutation of the immunoglobulin heavy chain gene variable region of de novo diffuse large B-cell lymphoma.
    Kikuchi T; Tokunaka M; Kikuti YY; Carreras J; Ogura G; Takekoshi S; Kojima M; Ando K; Hashimoto Y; Abe M; Takata K; Yoshino T; Muto A; Igarashi K; Nakamura N
    Pathol Int; 2013 Jul; 63(7):339-44. PubMed ID: 23865571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
    Seifert M; Küppers R
    Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.
    Gu X; Booth CJ; Liu Z; Strout MP
    Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bach2 regulates AID-mediated immunoglobulin gene conversion and somatic hypermutation in DT40 B cells.
    Budzyńska PM; Kyläniemi MK; Kallonen T; Soikkeli AI; Nera KP; Lassila O; Alinikula J
    Eur J Immunol; 2017 Jun; 47(6):993-1001. PubMed ID: 28301039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas.
    Ye X; Ren W; Liu D; Li X; Li W; Wang X; Meng FL; Yeap LS; Hou Y; Zhu S; Casellas R; Zhang H; Wu K; Pan-Hammarström Q
    J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33136155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent targets of aberrant somatic hypermutation in lymphoma.
    Khodabakhshi AH; Morin RD; Fejes AP; Mungall AJ; Mungall KL; Bolger-Munro M; Johnson NA; Connors JM; Gascoyne RD; Marra MA; Birol I; Jones SJ
    Oncotarget; 2012 Nov; 3(11):1308-19. PubMed ID: 23131835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.
    Hübschmann D; Kleinheinz K; Wagener R; Bernhart SH; López C; Toprak UH; Sungalee S; Ishaque N; Kretzmer H; Kreuz M; Waszak SM; Paramasivam N; Ammerpohl O; Aukema SM; Beekman R; Bergmann AK; Bieg M; Binder H; Borkhardt A; Borst C; Brors B; Bruns P; Carrillo de Santa Pau E; Claviez A; Doose G; Haake A; Karsch D; Haas S; Hansmann ML; Hoell JI; Hovestadt V; Huang B; Hummel M; Jäger-Schmidt C; Kerssemakers JNA; Korbel JO; Kube D; Lawerenz C; Lenze D; Martens JHA; Ott G; Radlwimmer B; Reisinger E; Richter J; Rico D; Rosenstiel P; Rosenwald A; Schillhabel M; Stilgenbauer S; Stadler PF; Martín-Subero JI; Szczepanowski M; Warsow G; Weniger MA; Zapatka M; Valencia A; Stunnenberg HG; Lichter P; Möller P; Loeffler M; Eils R; Klapper W; Hoffmann S; Trümper L; ; ; ; Küppers R; Schlesner M; Siebert R
    Leukemia; 2021 Jul; 35(7):2002-2016. PubMed ID: 33953289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
    Yang SY; Fugmann SD; Schatz DG
    J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies.
    Xu-Monette ZY; Li J; Xia Y; Crossley B; Bremel RD; Miao Y; Xiao M; Snyder T; Manyam GC; Tan X; Zhang H; Visco C; Tzankov A; Dybkaer K; Bhagat G; Tam W; You H; Hsi ED; van Krieken JH; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Piris MA; Winter JN; Medeiros JT; Xu B; Li Y; Kirsch I; Young KH
    J Immunother Cancer; 2019 Oct; 7(1):272. PubMed ID: 31640780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
    Lossos IS; Levy R; Alizadeh AA
    Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
    Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing somatic hypermutation in Ramos B cells after overexpression or knockdown of specific genes.
    Upton DC; Unniraman S
    J Vis Exp; 2011 Nov; (57):e3573. PubMed ID: 22083360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions.
    Spence JM; Abumoussa A; Spence JP; Burack WR
    J Immunol; 2014 Nov; 193(10):4888-94. PubMed ID: 25311808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma.
    Arthur SE; Jiang A; Grande BM; Alcaide M; Cojocaru R; Rushton CK; Mottok A; Hilton LK; Lat PK; Zhao EY; Culibrk L; Ennishi D; Jessa S; Chong L; Thomas N; Pararajalingam P; Meissner B; Boyle M; Davidson J; Bushell KR; Lai D; Farinha P; Slack GW; Morin GB; Shah S; Sen D; Jones SJM; Mungall AJ; Gascoyne RD; Audas TE; Unrau P; Marra MA; Connors JM; Steidl C; Scott DW; Morin RD
    Nat Commun; 2018 Oct; 9(1):4001. PubMed ID: 30275490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
    Komori A; Xu Z; Wu X; Zan H; Casali P
    Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinase-mediated cassette exchange as a novel method to study somatic hypermutation in Ramos cells.
    Baughn LB; Kalis SL; MacCarthy T; Wei L; Fan M; Bergman A; Scharff MD
    mBio; 2011; 2(5):. PubMed ID: 21990614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin's lymphomas with high rates of somatic hypermutation.
    Catherwood MA; Gonzalez D; Patton C; Dobbin E; Venkatraman L; Alexander HD
    J Clin Pathol; 2007 May; 60(5):524-8. PubMed ID: 16816169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
    Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
    Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
    McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
    J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.